Manuelli, Valeria
Cahill, Fidelma
Wylie, Harriet
Gillett, Cheryl
Correa, Isabel
Heck, Susanne
Rimmer, Alex
Haire, Anna
Van Hemelrijck, Mieke
Rudman, Sarah
Wells, Claire M.
Funding for this research was provided by:
Medical Research Council (MRC-DTP)
UK Research and Innovation
Pancreatic Cancer Research Fund (project 2017, project 2017)
Cancer Research UK (C604/A25135, C604/A25135)
Article History
Received: 22 October 2021
Accepted: 16 March 2022
First Online: 9 April 2022
Declarations
:
: The study was conducted upon the obtainment of written informed consent and under the King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB) [CitationRef removed] blinding protocols for the protection of patients’ identities and sensitive data. In vivo experiments were carried out in accordance with relevant guidelines and regulations. The study was carried out in compliance with the ARRIVE guidelines. Study has been approved by the King’s College Ethical Review Committee.
: Not applicable.
: The Authors declare there are no competing financial interests in relation to the work described.